Gijs F. De Wit
Utrecht, UT, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Reintroduction of palliative intent FOLFIRINOX chemotherapy in a real world pancreatic cancer cohort.
Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Published: June 21, 2024
Safety, Efficacy, and Biomarker Analysis of Crizotinib in MET-Mutated Non-Small Cell Lung Cancer-Results from the Drug Rediscovery Protocol.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 21, 2024
The Innate Immune Landscape of dMMR/MSI Cancers Predicts the Outcome of Nivolumab Treatment: Results from the Drug Rediscovery Protocol.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 12, 2024
Characterization of discordance between mismatch repair deficiency and microsatellite instability testing may prevent inappropriate treatment with immunotherapy.
Journal: The Journal of pathology
Published: October 09, 2023
Efficacy and Safety of Panitumumab in Patients With RAF/RAS-Wild-Type Glioblastoma: Results From the Drug Rediscovery Protocol.
Journal: The oncologist
Published: June 29, 2023
Efficacy, safety and biomarker analysis of durvalumab in patients with mismatch-repair deficient or microsatellite instability-high solid tumours.
Journal: BMC cancer
Published: December 20, 2022
A pan-cancer analysis of the microbiome in metastatic cancer.
Journal: Cell
Published: October 11, 2022
γδ T cells are effectors of immunotherapy in cancers with HLA class I defects.
Journal: Nature
Published: July 16, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026